Marin Biologic Laboratories

Marin Biologic Laboratories is a Contract Laboratory Services company with a stronghold in Cell Based Assays. Founded in 1995, the company is a woman PhD owned and managed Contract Research Laboratory specializing in the research, pre-clinical and clinical development and validation of cell based assays and immunoassays for biotech and pharmaceutical companies in Phase I/II or Phase III stages. Acting as a pioneer in the fields of cell biology, immunology, molecular biology, and biochemistry, Marin Biologic has positioned itself at the forefront of scientific development. They are compliant with U.S. FDA cGMP/GLP standards as well as ICH for all levels of clinical development, ensuring high-quality compliance with all regulatory standards. The company's unique approach to collaboration encourages scientists to communicate and create better science. Despite being located in Novato, California, the company has a diverse client and project list, reflecting its strong reputation and capabilities in delivering innovative and timely solutions to complex projects. It is evident that Marin Biologic Laboratories is led by a team of professionals with a deep-rooted scientific expertise, evident from the leadership of Tania Weiss, PhD, CEO and Peter Ralph, PhD, VP Science. Their approach to complementing client needs with scientific knowledge positions them as a key partner for companies seeking expertise in cell-based assays. Marin Biologic Laboratories presents an interesting investment opportunity within the biotechnology and manufacturing sectors for venture capitalists seeking to support innovative and compliant service providers in the life sciences industry. The company's commitment to good scientific processes and diverse scientific opportunities makes it an attractive prospect for potential investors. More information can be found at www.marinbio.com.